JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Health Care β€Ί VEEV

Are analysts right about Veeva Systems (VEEV)?

Health Care Β· price $310 Β· median target $295 (-5%)
In short β€” Over the past 12 months, 49% of analyst price targets on Veeva Systems turned out profitable, for an average return of +18% (across 296 timestamped calls). The current consensus is "Buy" with a median price target of $295 (-5% vs the current $310, from 20 analysts).

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on Veeva Systems β€” Financials & fundamentals  Β·  If I had invested
Current price
$310
Median target (12 mo)
$295 -5%
Analyst accuracy (1 yr)
49%
Avg return / call (1 yr)
+18%
πŸ’° Performance & Β« if I invested Β» πŸ“Š Interactive analysis

Historical analyst accuracy

For Veeva Systems, we replayed every analyst price target of the past 12 months and measured the real outcome: 49% were profitable, average return +18% (296 calls). At 3 months: +4% average return (42% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) β€” not a forecast of what will happen.

Analyst / brokerCalls i% profitable iAvg return i
Morgan Stanley3269%+31%
Needham2737%+8%
Piper Sandler2650%+16%
Keybanc2157%+20%
Stifel1963%+35%

Valuation

Is Veeva Systems overvalued, and is it a good time to buy Veeva Systems right now? If you're wondering, here's a recap to make up your own mind: Veeva Systems's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.

The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β€” but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.

MetricVeeva SystemsSector median (Health Care)
P/E50.929.4
Forward P/E30.317.9
Net margin29%13%

πŸ‘‰ Veeva Systems trades above its sector median (50.9 vs 29.4) β€” the market expects higher growth; watch out for disappointment.

πŸ“– P/E, PEG, margin…: see the glossary

Frequently asked questions

Is Veeva Systems a buy right now?

The analyst consensus on Veeva Systems (VEEV) is "Buy" (47 bullish, 1 bearish calls over 12 months). This is not advice: historically, 49% of their targets on this stock turned out profitable over 1 year.

What is Veeva Systems's price target?

The median 12-month price target is $295 (-5% vs $310), ranging from $165 to $375 (20 analysts).

Are analysts accurate on Veeva Systems?

Over 1 year, 49% of analyst targets on Veeva Systems were profitable, for an average return of +18% (across 296 timestamped calls). This is JPI Invest's accuracy metric.

What is the Veeva Systems stock forecast?

Analysts target a median of $295 within 12 months, i.e. -5% vs the current price. The most bullish targets $375, the most cautious $165.

What is the Veeva Systems stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $295, -5%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (49%), and the stock's past trajectory.

Is Veeva Systems overvalued?

Its P/E is 50.9, forward P/E 30.3. A forward P/E lower than the current P/E means earnings are expected to grow.

πŸ“Š See the full interactive analysis of Veeva Systems β†’

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.